Nicholas Piramal: New products make up for anti–infective decline - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  
  • Home
  • Outlook Arena
  • Jul 24, 2000 - Nicholas Piramal: New products make up for anti–infective decline

Nicholas Piramal: New products make up for anti–infective decline

Jul 24, 2000

Despite a 12% degrowth in anti–infectives in the first quarter, Nicholas Piramal has managed to report a 32% growth in bottomline. This was primarily on the back of new introductions such Rejoint (a nutraceutical consumed by arthirtis patients) and Haemaccel and Omnatax which were taken over from Hoechst.

(Rs m)1QFY001QFY01Change
Sales 1,121 1,325 18.2%
Other Income 14 12 -12.5%
Expenditure 938 1,098 17.1%
Operating Profit (EBDIT) 184 227 23.6%
Operating Profit Margin (%)16.4%17.1% 
Interest (net) 43 40  
Depreciation 25 33 32.3%
Profit before Tax13016628.0%
Other Adjustments   
Tax 15 14 -6.7%
Profit after Tax/(Loss) 115 152 32.5%
Net profit margin (%)10.2%11.5% 
No. of Shares (m) (eoy)27.734.9 
Diluted no. of shares (m)34.934.9 
Diluted Earnings per share*13.217.4 
*(annualised)   

The company has launched new products including Bulaquin (an anti–malarial), Alginic Acid (a gastrointestinal), atorvastatin (a cardiovascular) and cefixime (anti–infective). These are expected to contribute to the turnover in the subsequent quarters.

The stock quotes at a price of Rs 336 which implies an earning multple of 19.3 times on the annualised earnings for FY2001.

Equitymaster requests your view! Post a comment on "Nicholas Piramal: New products make up for anti–infective decline". Click here!

  

More Views on News

PIRAMAL ENTERPRISES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY22); Net Profit Down 20.0% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (down 20.0% YoY). Sales on the other hand came in at Rs 29 bn (down 1.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Nov 29, 2021 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS